Every JMS operation is built on a foundation of regulatory excellence — SFDA-licensed, ISO-certified, and GDP-compliant at every stage of the supply chain.
JMS holds all mandatory and voluntary certifications required to operate the highest-quality pharmaceutical distribution in Saudi Arabia.
Full pharmaceutical wholesale distribution license issued by the Saudi Food and Drug Authority — covering all product categories including controlled substances.
Quality Management System certification confirming that JMS's operations meet international standards for process excellence, consistency, and continuous improvement.
Full compliance with EU GDP guidelines adopted by SFDA — covering personnel, premises, equipment, documentation, operations, complaints, returns, and outsourced activities.
All cold rooms and refrigerated vehicles validated through WHO-standard temperature mapping studies with documented protocols and qualified systems.
Licensed to store and distribute narcotics, psychotropics, and controlled substances under strict MOH regulatory oversight with dedicated vault storage.
All facilities comply with Saudi Civil Defense requirements and OSHA-aligned health and safety standards for pharmaceutical warehousing operations.
JMS's quality policy is anchored in five fundamental commitments that govern every aspect of pharmaceutical handling and distribution.
"Quality is not an action, it is a habit. At JMS, every process, every decision, and every delivery reflects our unwavering commitment to patient safety and regulatory excellence."
Every quality decision prioritizes the safety and wellbeing of the patients who ultimately depend on the products we distribute.
Proactive engagement with all SFDA requirements, guidelines, and amendments to maintain full licensure and compliance at all times.
Regular internal audits, KPI monitoring, deviation management, and CAPA systems drive ongoing operational improvement.
All staff receive GDP, cold-chain, and quality training — with qualified persons overseeing all regulated activities.
Track-and-trace systems enable rapid, batch-level product recall from the entire distribution network within hours.
Dedicated pharmacovigilance processes ensure timely reporting of adverse events, quality complaints, and product defects to manufacturers and SFDA.
JMS's GDP framework covers all 12 chapters of EU Good Distribution Practice guidelines as adopted by SFDA.
QMS, quality policy, and documented procedures
Qualified persons, training & competence
Facility design, calibration & maintenance
SOPs, records & audit trails
Receipt, picking, dispatch & delivery
Complaint handling & return logistics
Track-and-trace & verification systems
3PL oversight & quality agreements
Internal audit programme & CAPA
Cold-chain transport validation & monitoring
Narcotics handling & security protocols
ICH Q9-aligned risk assessment & controls
Temperature-sensitive pharmaceuticals demand absolute precision. JMS operates fully validated cold-chain infrastructure from manufacturer receipt to final delivery.
Our cold rooms are built to WHO and SFDA standards, validated through temperature mapping studies, and equipped with IoT monitoring devices transmitting data continuously to our central control system. Every cold-chain vehicle carries calibrated monitoring devices with real-time data availability.
From receipt of biologics and vaccines to last-mile delivery, no product leaves our facilities without verified temperature integrity.
Refrigerated zones for biologics, vaccines, insulin & APIs
Climate-controlled zones for controlled room temperature products
IoT sensors with automated alarms & redundant backup systems
SFDA-compliant vehicles with real-time temperature monitoring
Fully validated infrastructure meeting SFDA & EU-GDP standards
Instant escalation protocols to prevent any temperature deviation
JMS's compliance infrastructure gives pharmaceutical manufacturers the regulatory certainty they need to succeed in the Saudi market.
